- $215.87m
- $160.58m
- $425.17m
- 28
- 70
- 20
- 34
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 390 | 362 | 387 | 406 | 425 |
Cost of Revenue | |||||
Gross Profit | 268 | 250 | 266 | 276 | 290 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 487 | 425 | 498 | 400 | 521 |
Operating Profit | -96.5 | -63.3 | -111 | 6.16 | -95.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -102 | -82.2 | -131 | 4.26 | -97.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | -104 | -83.1 | -131 | 3 | -92.2 |
Net Income Before Extraordinary Items | |||||
Net Income | -104 | -83.1 | -131 | 3 | -92.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -104 | -83.1 | -131 | 3 | -92.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -3.33 | -2.35 | -3.32 | -1.76 | -2.6 |